D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 71 Citations 17,730 199 World Ranking 14487 National Ranking 152

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Internal medicine
  • Enzyme

Her primary scientific interests are in Cannabinoid receptor, Cannabinoid, Endocrinology, Internal medicine and Receptor. Catherine Ledent interconnects Developmental psychology, Knockout mouse, Neuroscience and Endocannabinoid system in the investigation of issues within Cannabinoid receptor. The Cannabinoid study combines topics in areas such as Cannabinoid Receptor Modulators, Immunology, Cannabinoid receptor type 2, Wild type and Elevated plus maze.

Her research integrates issues of Adenosine A2A receptor, Adenosine receptor and Pharmacology in her study of Endocrinology. Her Internal medicine research incorporates themes from Cytotoxic T cell, PTC Oncogene, Genetically modified mouse and T-cell receptor. Her Receptor research focuses on Cell biology and how it connects with Programmed cell death.

Her most cited work include:

  • Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice (1197 citations)
  • Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. (799 citations)
  • Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission (526 citations)

What are the main themes of her work throughout her whole career to date?

Her main research concerns Internal medicine, Endocrinology, Receptor, Pharmacology and Cannabinoid receptor. Internal medicine connects with themes related to Wild type in her study. Her Endocrinology research includes themes of Adenosine A2A receptor, Knockout mouse and CGS-21680.

Her Receptor research incorporates elements of Dopaminergic, Striatum and Cell biology. Her study in Pharmacology is interdisciplinary in nature, drawing from both Agonist, Nucleus accumbens, Dopamine and Caffeine. Her Cannabinoid receptor study combines topics from a wide range of disciplines, such as Cannabinoid, Neuroscience and Endocannabinoid system.

She most often published in these fields:

  • Internal medicine (49.47%)
  • Endocrinology (48.06%)
  • Receptor (34.98%)

What were the highlights of her more recent work (between 2010-2021)?

  • Internal medicine (49.47%)
  • Endocrinology (48.06%)
  • Adenosine (25.44%)

In recent papers she was focusing on the following fields of study:

Catherine Ledent mainly focuses on Internal medicine, Endocrinology, Adenosine, Adenosine receptor and Pharmacology. Her study brings together the fields of Downregulation and upregulation and Internal medicine. Her Endocrinology research integrates issues from Cannabinoid, Knockout mouse, Epoxide hydrolase 2, Endocannabinoid system and Cannabinoid receptor.

Her Cannabinoid receptor study integrates concerns from other disciplines, such as Glutamate receptor, Glutamatergic and Neuroscience, Central nervous system. The various areas that Catherine Ledent examines in her Adenosine study include CGS-21680, Receptor, Coronary circulation, Reactive hyperemia and Adenosine A2A receptor. In her research on the topic of Pharmacology, Dopaminergic is strongly related with Nucleus accumbens.

Between 2010 and 2021, her most popular works were:

  • A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. (102 citations)
  • Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice (93 citations)
  • Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum. (51 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Enzyme

Her primary areas of study are Adenosine A2A receptor, Endocrinology, Internal medicine, Adenosine and Adenosine receptor. Adenosine A2A receptor is the subject of her research, which falls under Receptor. Within one scientific family, Catherine Ledent focuses on topics pertaining to Caffeine under Receptor, and may sometimes address concerns connected to Receptor antagonist.

Her Endocrinology study combines topics in areas such as Cannabinoid and Chromatin remodeling. The study incorporates disciplines such as Macrophage and Pharmacology in addition to Adenosine. Her studies deal with areas such as Signal transduction, Cell biology, Knockout mouse and Coronary circulation as well as Adenosine receptor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice

Catherine Ledent;Olga Valverde;Gregorio Cossu;François Petitet.
Science (1999)

1426 Citations

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.

Catherine Ledent;Jean-Marie Vaugeois;Serge N. Schiffmann;Thierry Pedrazzini.
Nature (1997)

1023 Citations

Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission

István Katona;Ede A. Rancz;László Acsády;Catherine Ledent.
The Journal of Neuroscience (2001)

665 Citations

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.

Fatima Teixeira-Clerc;Boris Julien;Boris Julien;Pascale Grenard;Pascale Grenard;Jeanne Tran Van Nhieu;Jeanne Tran Van Nhieu.
Nature Medicine (2006)

647 Citations

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.

Norbert Hájos;Catherine Ledent;Tamás F Freund.
Neuroscience (2001)

602 Citations

Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

Norbert Hájos;István Katona;S S Naiem;Ken Mackie.
European Journal of Neuroscience (2000)

588 Citations

Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses

István Katona;Gabriella M. Urbán;Matthew Wallace;Catherine Ledent.
The Journal of Neuroscience (2006)

548 Citations

Involvement of CB1 cannabinoid receptors in emotional behaviour.

Miquel Martin;Catherine Ledent;Marc Parmentier;Rafael Maldonado.
Psychopharmacology (2002)

536 Citations

Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus.

Namita Varma;Gregory C. Carlson;Catherine Ledent;Bradley E. Alger.
The Journal of Neuroscience (2001)

467 Citations

Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A2B Adenosine Receptors

Tobias Eckle;Thomas Krahn;Almut Grenz;David Köhler.
Circulation (2007)

457 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Catherine Ledent

Ken Mackie

Ken Mackie

Indiana University

Publications: 165

Rafael Maldonado

Rafael Maldonado

Pompeu Fabra University

Publications: 120

Rodrigo A. Cunha

Rodrigo A. Cunha

University of Coimbra

Publications: 108

Vincenzo Di Marzo

Vincenzo Di Marzo

Université Laval

Publications: 103

Holger K. Eltzschig

Holger K. Eltzschig

The University of Texas Health Science Center at Houston

Publications: 96

Beat Lutz

Beat Lutz

Johannes Gutenberg University of Mainz

Publications: 90

Giovanni Marsicano

Giovanni Marsicano

University of Bordeaux

Publications: 89

Mauro Maccarrone

Mauro Maccarrone

University of L'Aquila

Publications: 80

Mercè Correa

Mercè Correa

Jaume I University

Publications: 78

Daniele Piomelli

Daniele Piomelli

University of California, Irvine

Publications: 76

Pal Pacher

Pal Pacher

National Institutes of Health

Publications: 75

Sergi Ferré

Sergi Ferré

National Institute on Drug Abuse

Publications: 71

Cecilia J. Hillard

Cecilia J. Hillard

Medical College of Wisconsin

Publications: 63

George Kunos

George Kunos

National Institutes of Health

Publications: 61

Christa E. Müller

Christa E. Müller

University of Bonn

Publications: 59

Benjamin F. Cravatt

Benjamin F. Cravatt

Scripps Research Institute

Publications: 59

Trending Scientists

Thinh Nguyen

Thinh Nguyen

Oregon State University

Anthony Linden

Anthony Linden

University of Zurich

Ryoji Kasai

Ryoji Kasai

Hiroshima University

Christian Slugovc

Christian Slugovc

Graz University of Technology

Miria Stefanini

Miria Stefanini

University of Pavia

Peter A. Lindsey

Peter A. Lindsey

Griffith University

Wolfgang Kneifel

Wolfgang Kneifel

University of Natural Resources and Life Sciences

Giovanna Ferro-Luzzi Ames

Giovanna Ferro-Luzzi Ames

University of California, Berkeley

marius ueffing

marius ueffing

University of Tübingen

Tine Rask Licht

Tine Rask Licht

Technical University of Denmark

Akira Yokota

Akira Yokota

University of Tokyo

Pierre Payment

Pierre Payment

Institut National de la Recherche Scientifique

Annika Seppälä

Annika Seppälä

University of Otago

Antoine Grémare

Antoine Grémare

University of Bordeaux

Thomas M. Coffman

Thomas M. Coffman

National University of Singapore

Karen Seashore Louis

Karen Seashore Louis

University of Minnesota

Something went wrong. Please try again later.